Hironobu Shirataki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hironobu Shirataki has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Yoshiro Yokoyama
Asahi Kasei Medical Co Ltd
6 shared publicationsS. Ranil Wickramasinghe
4 shared publications- Sumith Ranil Wickramasinghe
University of Arkansas
4 shared publications Xianghong Qian
3 shared publications- Daniel Strauss
Asahi Kasei Bioprocess America, Inc. Glenview Illinois USA
2 shared publications Fuminori Konoike
Bio‐Pharma Research Laboratories Kaneka Corporation Hyogo Japan
2 shared publications
Latest Publications
- Open Access
- 3 April 2026
- Published by Elsevier in Journal of Membrane Science
- Vol. 750
Modeling the effect of monoclonal antibody on the performance of small virus filters using an advanced multilayer membrane model
- 3 April 2026
- Published by Elsevier in Journal of Membrane Science
- Vol. 750
Open AccessModeling the effect of monoclonal antibody on the performance of small virus filters using an advanced multilayer membrane model
- Open Access
- 21 February 2026
- Published by Elsevier in SSRN Electronic Journal
Modeling The Effect of Monoclonal Antibody on the Performance of Small Virus Filters Using an Advanced Multilayer Membrane Model
Virus filters achieve high log reduction value (LRV) while maintaining high permeability and high target protein recovery. Performance arises from carefully controlled asymmetry in both porosity and pore size distribution. In this study, the unique multilayer membrane model that accounts for both these effects was applied to quantify and compare the structural characteristics—porosity and pore size distribution—of three small virus filters (Planova 20N, Planova S20N, and Planova BioEX; Asahi Kasei Life Science). Experimental data were obtained from constant-flux filtration (75 LMH) of PBS solutions spiked with minute virus of mice (MVM). The model successfully reproduced MVM retention profiles within the membranes, revealing structural differences among the filters. Additionally, PBS containing 5 g/L monoclonal antibody (mAb) and MVM was filtered under identical conditions. By modeling transmembrane pressure (TMP) profiles, the composition of mAb aggregates was optimized, indicating trace levels of trimers or higher-order aggregates below the SEC detection limit (0.01%). The presence of the mAb shifted the peak of the MVM retention distribution toward the permeate side compared with protein-free conditions. Model analysis suggests this shift results from displacement of initially trapped MVM by reversible mAb aggregates within the pores. Filtration behavior varied among the filters, reflecting differences in filter structure. Experimental observations indicate that the presence of a product mAb can lead to a change in virus capture profile. To our knowledge, this is the first multilayer model that predicts this effect, providing insights for optimizing virus filtration in biopharmaceutical processes.
- 21 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessModeling The Effect of Monoclonal Antibody on the Performance of Small Virus Filters Using an Advanced Multilayer Membrane Model
Virus filters achieve high log reduction value (LRV) while maintaining high permeability and high target protein recovery. Performance arises from carefully controlled asymmetry in both porosity and pore size distribution. In this study, the unique multilayer membrane model that accounts for both these effects was applied to quantify and compare the structural characteristics—porosity and pore size distribution—of three small virus filters (Planova 20N, Planova S20N, and Planova BioEX; Asahi Kasei Life Science). Experimental data were obtained from constant-flux filtration (75 LMH) of PBS solutions spiked with minute virus of mice (MVM). The model successfully reproduced MVM retention profiles within the membranes, revealing structural differences among the filters. Additionally, PBS containing 5 g/L monoclonal antibody (mAb) and MVM was filtered under identical conditions. By modeling transmembrane pressure (TMP) profiles, the composition of mAb aggregates was optimized, indicating trace levels of trimers or higher-order aggregates below the SEC detection limit (0.01%). The presence of the mAb shifted the peak of the MVM retention distribution toward the permeate side compared with protein-free conditions. Model analysis suggests this shift results from displacement of initially trapped MVM by reversible mAb aggregates within the pores. Filtration behavior varied among the filters, reflecting differences in filter structure. Experimental observations indicate that the presence of a product mAb can lead to a change in virus capture profile. To our knowledge, this is the first multilayer model that predicts this effect, providing insights for optimizing virus filtration in biopharmaceutical processes.
- Open Access
Visualizing the Effect of Process Pause on Virus Entrapment During Constant Flux Virus Filtration
Virus filtration is an essential unit operation used to validate clearance of adventitious virus during the manufacture of biopharmaceutical products such as monoclonal antibodies. Obtaining at least a 10,000-fold reduction in virus particles in the permeate is challenging as monoclonal antibodies are about half the size of the virus particles. Minute virus of mice, FDA-recommended model adventitious virus, was labeled with a fluorescent dye. Laser scanning confocal microscopy was used to determine the location of virus entrapment within the virus filtration membrane. Three different hollow fiber membranes made of regenerated cellulose and polyvinylidene fluoride were tested. Feed streams consisted of MVM spiked in buffer and MVM spiked in 5 g L−1 bovine serum albumin known to contain aggregates similar in size to the MVM. After filtering the feed, a buffer flush was used, with and without 30 min pause before the buffer flush. For all virus filters, a 30 min process pause led to broadening and movement of the virus entrapment zone deeper into the membrane. The presence of aggregates led to greater broadening of the entrapment zone. Both effects could lead to reduced virus clearance. Visualization of virus entrapment helps improve understanding of the behavior of virus filtration membranes.
Open AccessVisualizing the Effect of Process Pause on Virus Entrapment During Constant Flux Virus Filtration
Virus filtration is an essential unit operation used to validate clearance of adventitious virus during the manufacture of biopharmaceutical products such as monoclonal antibodies. Obtaining at least a 10,000-fold reduction in virus particles in the permeate is challenging as monoclonal antibodies are about half the size of the virus particles. Minute virus of mice, FDA-recommended model adventitious virus, was labeled with a fluorescent dye. Laser scanning confocal microscopy was used to determine the location of virus entrapment within the virus filtration membrane. Three different hollow fiber membranes made of regenerated cellulose and polyvinylidene fluoride were tested. Feed streams consisted of MVM spiked in buffer and MVM spiked in 5 g L−1 bovine serum albumin known to contain aggregates similar in size to the MVM. After filtering the feed, a buffer flush was used, with and without 30 min pause before the buffer flush. For all virus filters, a 30 min process pause led to broadening and movement of the virus entrapment zone deeper into the membrane. The presence of aggregates led to greater broadening of the entrapment zone. Both effects could lead to reduced virus clearance. Visualization of virus entrapment helps improve understanding of the behavior of virus filtration membranes.
- Open Access
- 4 August 2025
- Published by Wiley in Biotechnology Progress
- Vol. 41 (6) , e70059
Harvesting AAV by tangential flow filtration using reverse asymmetric membranes
Efficient bioreactor clarification for harvesting virus particles is often challenging. Tangential flow filtration is attractive as it can be easily adapted for batch and perfusion operations. Here the feasibility of using reverse asymmetric hollow fiber membranes, where the more open support structure faces the feed stream, has been investigated for harvesting adeno associated virus serotype 2. The open support structure of these membranes stabilizes a secondary membrane consisting of rejected particulate matter. It is essential that the stabilized secondary membrane remains highly permeable. Flux stepping experiments were conducted in total recycle mode in order to determine the critical flux. The critical flux is the maximum stable flux. Higher fluxes lead to a rapid increase in transmembrane pressure under constant flux operation. The critical flux is shown to increase with increasing wall shear rate (feed flow rate). The reduction in turbidity of the permeate relative to the feed decreases with increasing wall shear rate. Harvesting adeno associated virus was conducted at a wall shear rate of 2000 s −1 . The permeate flux was set at 15 Lm −2 h −1 . The feed was concentrated till the transmembrane pressure reached 3.5 kPa. Diafiltration then commenced using 3 diavolumes. While commencing diafiltration with a smaller feed volume will reduce diluent usage and dilution of the product, it is essential that the transmembrane pressure is not too high to create a compacted low permeability secondary membrane. Here the transmembrane pressure was almost constant at 3.5 kPa during diafiltration. Virus recovery was 94%.
- 4 August 2025
- Published by Wiley in Biotechnology Progress
- Vol. 41 (6) , e70059
Open AccessHarvesting AAV by tangential flow filtration using reverse asymmetric membranes
Efficient bioreactor clarification for harvesting virus particles is often challenging. Tangential flow filtration is attractive as it can be easily adapted for batch and perfusion operations. Here the feasibility of using reverse asymmetric hollow fiber membranes, where the more open support structure faces the feed stream, has been investigated for harvesting adeno associated virus serotype 2. The open support structure of these membranes stabilizes a secondary membrane consisting of rejected particulate matter. It is essential that the stabilized secondary membrane remains highly permeable. Flux stepping experiments were conducted in total recycle mode in order to determine the critical flux. The critical flux is the maximum stable flux. Higher fluxes lead to a rapid increase in transmembrane pressure under constant flux operation. The critical flux is shown to increase with increasing wall shear rate (feed flow rate). The reduction in turbidity of the permeate relative to the feed decreases with increasing wall shear rate. Harvesting adeno associated virus was conducted at a wall shear rate of 2000 s −1 . The permeate flux was set at 15 Lm −2 h −1 . The feed was concentrated till the transmembrane pressure reached 3.5 kPa. Diafiltration then commenced using 3 diavolumes. While commencing diafiltration with a smaller feed volume will reduce diluent usage and dilution of the product, it is essential that the transmembrane pressure is not too high to create a compacted low permeability secondary membrane. Here the transmembrane pressure was almost constant at 3.5 kPa during diafiltration. Virus recovery was 94%.
- Open Access
- 14 March 2025
- Published by Elsevier in Journal of Membrane Science
- Vol. 724
Modelling virus filtration and virus reduction by an advanced multilayer model: Retention distribution and the effect of product aggregates
- 14 March 2025
- Published by Elsevier in Journal of Membrane Science
- Vol. 724
Open AccessModelling virus filtration and virus reduction by an advanced multilayer model: Retention distribution and the effect of product aggregates
- Open Access
Enhancing Virus Filter Performance Through Pretreatment by Membrane Adsorbers
Virus filtration is used to ensure the high level of virus clearance required in the manufacture of biopharmaceutical products such as monoclonal antibodies. Flux decline during virus filtration can occur due to the formation of reversible aggregates consisting of self-assembled monomeric monoclonal antibody molecules, particularly at high antibody concentrations. While size exclusion chromatography is generally unable to detect these reversible aggregates, dynamic light scattering may be used to determine their presence. Flux decline during virus filtration may be minimized by pretreating the feed using a membrane adsorber in order to disrupt the reversible aggregates that are present. The formation of reversible aggregates is highly dependent on the monoclonal antibody and the feed conditions. For the pH values investigated here, pretreatment of the feed using a hydrophobic interaction membrane adsorber was the most effective in minimizing flux decline during virus filtration. Ion exchange membranes may also be effective if the monoclonal antibody and membrane are oppositely charged. Consequently, the effectiveness of ion exchange membrane adsorbers is much more dependent on solution pH when compared to hydrophobic interaction membrane adsorbers. Size based prefiltration was found to be ineffective at disrupting these reversible aggregates. These results can help guide the development of more effective virus filtration processes for monoclonal antibody production.
Open AccessEnhancing Virus Filter Performance Through Pretreatment by Membrane Adsorbers
Virus filtration is used to ensure the high level of virus clearance required in the manufacture of biopharmaceutical products such as monoclonal antibodies. Flux decline during virus filtration can occur due to the formation of reversible aggregates consisting of self-assembled monomeric monoclonal antibody molecules, particularly at high antibody concentrations. While size exclusion chromatography is generally unable to detect these reversible aggregates, dynamic light scattering may be used to determine their presence. Flux decline during virus filtration may be minimized by pretreating the feed using a membrane adsorber in order to disrupt the reversible aggregates that are present. The formation of reversible aggregates is highly dependent on the monoclonal antibody and the feed conditions. For the pH values investigated here, pretreatment of the feed using a hydrophobic interaction membrane adsorber was the most effective in minimizing flux decline during virus filtration. Ion exchange membranes may also be effective if the monoclonal antibody and membrane are oppositely charged. Consequently, the effectiveness of ion exchange membrane adsorbers is much more dependent on solution pH when compared to hydrophobic interaction membrane adsorbers. Size based prefiltration was found to be ineffective at disrupting these reversible aggregates. These results can help guide the development of more effective virus filtration processes for monoclonal antibody production.
- Open Access
- 13 July 2023
- Published by Elsevier in Journal of Membrane Science
- Vol. 685
Predicting virus filter performance using an advanced membrane structural model
- 13 July 2023
- Published by Elsevier in Journal of Membrane Science
- Vol. 685
Open AccessPredicting virus filter performance using an advanced membrane structural model
- Open Access
- 8 June 2023
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 120 (10) , 2977-2988
Viral clearance in end‐to‐end integrated continuous process for mAb purification: Total flow‐through integrated polishing on two columns connected to virus filtration
There are few reports of the adoption of continuous processes in bioproduction, particularly the implementation of end‐to‐end continuous or integrated processes, due to difficulties such as feed adjustment and incorporating virus filtration. Here, we propose an end‐to‐end integrated continuous process for a monoclonal antibody (mAb) with three integrated process segments: upstream production processes with pool‐less direct connection, pooled low pH virus inactivation with pH control and a total flow‐through integrated polishing process in which two columns were directly connected with a virus filter. The pooled virus inactivation step defines the batch, and high impurities reduction and mAb recovery were achieved for batches conducted in succession. Viral clearance tests also confirmed robust virus reduction for the flow‐through two‐column chromatography and the virus filtration steps. Additionally, viral clearance tests with two different hollow fiber virus filters operated at flux ranging from 1.5 to 40 LMH (liters per effective surface area of filter in square meters per hour) confirmed robust virus reduction over these ranges. Complete clearance with virus logarithmic reduction value ≥4 was achieved even with a process pause at the lowest flux. The end‐to‐end integrated continuous process proposed in this study is amenable to production processes, and the investigated virus filters have excellent applicability to continuous processes conducted at constant flux.
- 8 June 2023
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 120 (10) , 2977-2988
Open AccessViral clearance in end‐to‐end integrated continuous process for mAb purification: Total flow‐through integrated polishing on two columns connected to virus filtration
There are few reports of the adoption of continuous processes in bioproduction, particularly the implementation of end‐to‐end continuous or integrated processes, due to difficulties such as feed adjustment and incorporating virus filtration. Here, we propose an end‐to‐end integrated continuous process for a monoclonal antibody (mAb) with three integrated process segments: upstream production processes with pool‐less direct connection, pooled low pH virus inactivation with pH control and a total flow‐through integrated polishing process in which two columns were directly connected with a virus filter. The pooled virus inactivation step defines the batch, and high impurities reduction and mAb recovery were achieved for batches conducted in succession. Viral clearance tests also confirmed robust virus reduction for the flow‐through two‐column chromatography and the virus filtration steps. Additionally, viral clearance tests with two different hollow fiber virus filters operated at flux ranging from 1.5 to 40 LMH (liters per effective surface area of filter in square meters per hour) confirmed robust virus reduction over these ranges. Complete clearance with virus logarithmic reduction value ≥4 was achieved even with a process pause at the lowest flux. The end‐to‐end integrated continuous process proposed in this study is amenable to production processes, and the investigated virus filters have excellent applicability to continuous processes conducted at constant flux.
- Open Access
- 21 March 2023
- Published by Elsevier in Biochemical Engineering Journal
- Vol. 194
Modeling virus filtration based on a multilayer membrane morphology and pore size distribution
- 21 March 2023
- Published by Elsevier in Biochemical Engineering Journal
- Vol. 194
Open AccessModeling virus filtration based on a multilayer membrane morphology and pore size distribution